151 related articles for article (PubMed ID: 24520244)
21. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
Yu F; Zhu X; Yuan S; Chen X; Li Z; Qu Z; Liu H; Sun L; Liu F
Ann Med; 2021 Dec; 53(1):587-595. PubMed ID: 33825605
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroids Improve Renal Survival: A Retrospective Analysis From Chinese Patients With Early-Stage IgA Nephropathy.
Qin A; Pei G; Tang Y; Tan L; Wei X; Zhong Z; Zhou L; Chen C; Qin W
Front Med (Lausanne); 2020; 7():585859. PubMed ID: 33195345
[No Abstract] [Full Text] [Related]
24. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy.
Sakagami Y; Nakajima M; Takagawa K; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Kamitsuji H; Yoshioka A
Nephron Clin Pract; 2004; 96(3):c96-104. PubMed ID: 15056992
[TBL] [Abstract][Full Text] [Related]
25. Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.
Nakayama K; Ohsawa I; Maeda-Ohtani A; Murakoshi M; Horikoshi S; Tomino Y
J Clin Lab Anal; 2008; 22(2):114-8. PubMed ID: 18348316
[TBL] [Abstract][Full Text] [Related]
26. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
Chen MG; Ye XH; Liang HY; Yang Q
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
[TBL] [Abstract][Full Text] [Related]
28. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
; Jiang XY
Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
.
Ihm HS; Lee JY; Hwang HS; Kim YG; Moon JY; Lee SH; Jeong KH; Lee TW; Ihm CG
Clin Nephrol; 2019 Sep; 92(3):131-140. PubMed ID: 31232271
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
Harmankaya O; Oztürk Y; Baştürk T; Obek A; Kiliçarslan I
Int Urol Nephrol; 2002; 33(1):167-71. PubMed ID: 12090325
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy.
Wada Y; Ogata H; Takeshige Y; Takeshima A; Yoshida N; Yamamoto M; Ito H; Kinugasa E
Clin Exp Nephrol; 2013 Feb; 17(1):73-82. PubMed ID: 22752397
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic features and prognosis of patients with IgA nephropathy superimposed on transplant glomerulopathy].
Li X; Chen JS; Cheng DR; Ji SM; Xie KN; Ni XF; Wen JQ; Tang Z
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):889-894. PubMed ID: 30917436
[No Abstract] [Full Text] [Related]
35. Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura.
Dumont C; Mérouani A; Ducruet T; Benoit G; Clermont MJ; Lapeyraque AL; Phan V; Patey N
Pediatr Nephrol; 2020 May; 35(5):843-850. PubMed ID: 31932958
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function.
Tan M; Fang J; Xu Q; Zhang C; Zou G; Wang M; Li W
Ren Fail; 2019 Nov; 41(1):875-882. PubMed ID: 31517550
[No Abstract] [Full Text] [Related]
37. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive therapy for active IgA nephropathy is effective and safe, even in "elderly" patients.
Fukuda M; Hotta O; Mizuno M; Ogiyama Y; Ohte N
Clin Exp Nephrol; 2016 Dec; 20(6):832-834. PubMed ID: 27443481
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis.
Liu Y; Xiao J; Shi X; Hao G; Chen Q; Zhou J; Wei X
Exp Ther Med; 2016 Jan; 11(1):49-56. PubMed ID: 26889216
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of childhood IgA nephropathy with minimal proteinuria.
Higa A; Shima Y; Hama T; Sato M; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Nakanishi K; Yoshikawa N
Pediatr Nephrol; 2015 Dec; 30(12):2121-7. PubMed ID: 26238276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
